Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2003-12-19 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANGERS (49000), Maine-et-Loire
PHARMACIE DES JUSTICES : revenue, balance sheet and financial ratios
PHARMACIE DES JUSTICES is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANGERS (49000),
this company of category PME
shows in 2024 a revenue of 3.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES JUSTICES (SIREN 451592471)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
3 527 991 €
3 386 581 €
3 183 616 €
N/C
N/C
N/C
N/C
2 472 724 €
Net income
207 660 €
201 374 €
241 351 €
222 492 €
120 677 €
125 260 €
157 549 €
152 931 €
154 769 €
EBITDA
N/C
267 983 €
327 947 €
308 322 €
N/C
N/C
N/C
N/C
191 001 €
Net margin
N/C
5.7%
7.1%
7.0%
N/C
N/C
N/C
N/C
6.3%
Revenue and income statement
In 2025, PHARMACIE DES JUSTICES generates positive net income of 208 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 155 k€ -> 208 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
207 660 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.623%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.752%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES JUSTICES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
21.336
12.67
6.094
0.45
0.0
0.019
0.054
2.568
10.623
Financial autonomy
73.941
79.417
84.914
88.79
89.97
88.331
88.604
84.948
77.752
Repayment capacity
3.172
None
None
None
None
0.002
0.006
0.316
None
Cash flow / Revenue
4.963%
None%
None%
None%
None%
7.15%
7.101%
5.821%
None%
Sector positioning
Debt ratio
10.622025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DES JUSTICES (10.62) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
77.75%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of PHARMACIE DES JUSTICES (77.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.32 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Excellent
In 2024, the repayment capacity of PHARMACIE DES JUSTICES (0.32) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 201.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
201.228
Liquidity indicators evolution PHARMACIE DES JUSTICES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
147.141
147.908
166.682
164.206
192.093
235.608
243.898
209.111
201.228
Interest coverage
3.029
None
None
None
None
0.0
0.0
0.212
None
Sector positioning
Liquidity ratio
201.232025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-11 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES JUSTICES (201.23) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.21x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE DES JUSTICES (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES JUSTICES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
163 150 €
0 €
0 €
0 €
0 €
371 273 €
417 261 €
435 037 €
0 €
Inventory turnover (days)
24
0
0
0
0
19
20
17
0
Customer payment term (days)
6
0
0
0
0
5
4
4
0
Supplier payment term (days)
35
0
0
0
0
33
34
40
0
Positioning of PHARMACIE DES JUSTICES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES JUSTICES is estimated at
3 298 703 €
(range 2 238 515€ - 5 176 120€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2238k€3298k€5176k€
3 298 703 €Range: 2 238 515€ - 5 176 120€
NAF 5 année 2025
Valuation method used
Net Income Multiple
207 660 €
×
15.9x
=3 298 704 €
Range: 2 238 516€ - 5 176 120€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES JUSTICES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES JUSTICES
What is the revenue of PHARMACIE DES JUSTICES ?
The revenue of PHARMACIE DES JUSTICES in 2024 is 3.5 M€.
Is PHARMACIE DES JUSTICES profitable?
Yes, PHARMACIE DES JUSTICES generated a net profit of 208 k€ in 2025.
Where is the headquarters of PHARMACIE DES JUSTICES ?
The headquarters of PHARMACIE DES JUSTICES is located in ANGERS (49000), in the department Maine-et-Loire.
Where to find the tax return of PHARMACIE DES JUSTICES ?
The tax return of PHARMACIE DES JUSTICES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES JUSTICES operate?
PHARMACIE DES JUSTICES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart